Virchow Biotech Private Limited

Virchow Biotech Private Limited (VBPL) is an ISO 13485:2016 and WHO-GMP certified biopharmaceutical manufacturer established in 2001 in Hyderabad, India. With over 24 years of operational excellence, VBPL specializes in developing and manufacturing high-quality biogenerics, recombinant therapeutics, active pharmaceutical ingredients (APIs), and medical devices. The company is recognized as the first to commercialize biogenic formulations including Recombinant Platelet Derived Growth Factor (rhPDGF) for wound healing and Recombinant PTH for osteoporosis treatment. Additional key products include Pegylated Interferon and Rasburicase. VBPL operates advanced fermentation and recombinant biotech production facilities, offering contract research, manufacturing, co-development, and biopharmaceutical research services. With an annual turnover exceeding $1 billion and a workforce of over 5,000 professionals, the company maintains a global presence across 100+ countries with offices in the USA.